Increased levels of oxidative damage to DNA, lipids and proteins have been detected by a range of assays in post-mortem tissues from patients with Parkinsons disease, Alzheimers disease and amyotrophic lateral sclerosis, and at least some of these changes may occur early in disease progression
95% CI: 0.32-0.95), but not with fibrosis (OR: 0.86
standard monitoring | | 150 to 499 mg/dL (borderline to high) | 1 to 2 g EPA+DHA daily reasonable
The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes 14 metabolic pathways and 49 peptides, including key variants in GLP1R, GIPR, FTO, and MC4R genes
Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement